EichorEICHOR
Location: Southampton Synced from ClinicalTrials.gov · August 07, 2026

Clinical studies recruiting near Southampton

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks
NA · NIHR Clinical Research Facility · University of Southampton · NCT05847322
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6401 · Galderma R&D · NCT06988605
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · University Hospital Southampton NHS Foundation Trust · Pfizer · NCT06758401
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
Phase 3 · Site GB44004 · Astellas Pharma Global Development, Inc. · NCT05970172
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · University Hospital of Southampton · CellCentric Ltd. · NCT04068597
PMCF (Post-Market Clinical Follow-up) Study on The Tether™ in UK (United Kingdom)
Phase N/A · University Southampton Hospital · LDR Médical SAS · NCT05830825
Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
NA · Hampshire and Isle of Wight Healthcare NHS Foundation Trust · King's College London · NCT07228468
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Sele
NA · University Hospital Southampton NHS Foundation Trust · Alimentiv Inc. · NCT07363044
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1
Phase 2 · Gilead Sciences · NCT07645287
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Southampton General Hospital · Eli Lilly and Company · NCT07222332
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-
Phase 1 · Southampton General Hospital · Regeneron Pharmaceuticals · NCT05685173
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced S
Phase 1/Phase 2 · University Hospital Southampton NHS Foundation Trust · ModernaTX, Inc. · NCT05533697
BEARS Training Package to Maximise Hearing Abilities in Older Children and Teenagers With Bilateral Cochlear Implants
NA · University of Southampton Auditory Implant Service · Guy's and St Thomas' NHS Foundation Trust · NCT05808543
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Proto
Phase 3 · Southampton General Hospital - University Hospital Southampt · Tanabe Pharma America, Inc. · NCT05005975
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Phase 2 · Southampton General Hospital - University Hospital Southampt · Gesynta Pharma AB · NCT07260669
A Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
Phase 1 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07214727
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Southampton General Hospital · Janssen Research & Development, LLC · NCT06319820
ERP to Improve Functioning in Veterans With OCD
NA · VA Office of Research and Development · NCT05240924
Pan Tumor Rollover Study
Phase 2 · Local Institution - 0195 · Bristol-Myers Squibb · NCT03899155
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alon
Phase 1/Phase 2 · Southampton General Hospital · BioNTech SE · NCT07070232
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adul
Phase 2/Phase 3 · Southampton General Hospital · Cancer Research UK · NCT05786716
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06564038
High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Southampton General Hospital · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-39006, Southampton, UK · Colorado Prevention Center · NCT06033950
A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Bioluminux - Southampton · Eli Lilly and Company · NCT07420283
DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With H
Phase 2/Phase 3 · Southampton General Hospital · Cancer Research UK · NCT05770102
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Phase 1/Phase 2 · University of Southampton · Corbus Pharmaceuticals Inc. · NCT06265727
First in Human Study of T3P-Y058-739 (T3P)
Phase 1/Phase 2 · University Hospital Southampton NHS Foundation Trust · T3 Pharmaceuticals AG · NCT05120596
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Uniquity One (UNI) · NCT06496620
Look up another city
Look up another condition